Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
a5ZChyYy8r7sbMKm
